Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT02269605
Eligibility Criteria:
Inclusion Criteria:
* Patients understanding the trial purpose
* Patients between 18 and 50 years of age
* Patients with chronic HIV-1 infection
* Patients receiving antiretroviral treatment with at least 3 active drugs for at least 2 years
* Undetectable viral load measured by ultra sensitive methods
* CD4+ levels higher than 350 cells/mm3
* Patients committed to use contraceptive methods during the trial and up to 3 months after.
Exclusion Criteria:
* Previous antiretroviral treatment failure, as any viral load outbreak after having had undetectable HIV-1 load. Low grade, transitory outbreaks (\<200 RNA copies/ml) resolved without treatment modifications are excluded
* Patients planned to interrupt antiretroviral treatment during the trial
* Patients receiving immunosuppressant or immunostimulant drugs, including valproic acid.
* Pregnant women
* Bryostatin-1 hypersensitivity
* Being enrolled in another clinical trial or having participated in another clinical trial in the previous 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02269605
Study Brief:
Protocol Section:
NCT02269605